Health Care Archives - Page 38 of 478

2 minute read

Infection-Focused Barinthus Bio’s VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives

April 19, 11:49 AM

Explore the latest findings from Barinthus Biotherapeutics on VTP-200's performance in the APOLLO trial for low-grade cervical lesions linked to persistent hrHPV infection. Positive trends were noted, though not statistically significant. No major safety concerns were observed.

BRNS

2 minute read

Brexit Impact On Drugs – Rising Shortages in UK Highlight Brexit Challenges

By Vandana Singh

April 19, 11:39 AM

Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages since 2020. Learn about challenges in medicine supplies, regulatory hurdles, and global disruptions.

AZN

2 minute read

Johnson & Johnson Children’s Cough Syrup Contaminated In Some Batches – WHO Poised to Issue Global Alert

By Vandana Singh

April 19, 10:17 AM

WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway.

JNJ

1 minute read

FDA Mandates “Boxed Warning” For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies

By Vandana Singh

April 19, 9:28 AM

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel

BMY

2 minute read

Intuitive Surgical Q1 Earnings: Revenue Beat, EPS Beat, Surgical System Installed Base Up 14% And More

By Adam Eckert

April 18, 4:44 PM

Intuitive Surgical reported first-quarter revenue of $1.89 billion, which beat the consensus estimate of $1.87 billion, according to Benzinga Pro.

ISRG

2 minute read

German Authority Gives Go Ahead To Novo Nordisk’s Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline

By Vandana Singh

April 18, 1:55 PM

Novo Nordisk's acquisition of Cardior Pharmaceuticals clears regulatory hurdles, advancing cardiovascular treatment development with CDR132L. Learn about the promising phase 2 trials and strategic expansion. Deal expected to close Q2 2024.

NVO

2 minute read

Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study

By Vandana Singh

April 18, 1:44 PM

Discover toplines results of Cerevel Therapeutics' Phase 3 TEMPO-3 trial for tavapadon in Parkinson's disease treatment. Statistically significant efficacy and safety findings were revealed.

ABBV

1 minute read

Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder

By Vandana Singh

April 18, 1:37 PM

Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy. Significant DRSS improvement with no worsening observed. Positive Phase 2 data for Paxtrava also disclosed, showing substantial reduction in intraocular pressure.

OCUL

2 minute read

Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?

By Vandana Singh

April 18, 1:04 PM

Latest clinical data on BB-301 treatment for OPMD. Positive results in swallowing improvement. Benitec Biopharma announces interim findings and $40 million PIPE financing.

BNTC

2 minute read

Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025

By Vandana Singh

April 18, 12:50 PM

Facing a shortage, GLP-1 weight loss drugs by Eli Lilly & Novo Nordisk struggle to meet demand. Learn about supply issues and efforts to address them, impacting availability till 2025.

LLY